François Berger Selected Research

N(6)-methyldeoxyadenosine

5/2003

Induction of neurite outgrowth in PC12 cells by the bacterial nucleoside N6-methyldeoxyadenosine is mediated through adenosine A2a receptors and via cAMP and MAPK signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

François Berger Research Topics

Disease

20	Neoplasms (Cancer) 04/2017 - 05/2003
12	Glioma (Gliomas) 01/2022 - 04/2002
8	Glioblastoma (Glioblastoma Multiforme) 04/2017 - 03/2004
3	Hypoxia (Hypoxemia) 01/2022 - 09/2010
3	Parkinson Disease (Parkinson's Disease) 01/2016 - 11/2005
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014 - 01/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 01/2013
2	Brain Neoplasms (Brain Tumor) 01/2013 - 04/2002
2	Meningioma (Meningiomas) 05/2011 - 02/2010
2	Leukemia 03/2010 - 01/2008
2	Dyskinesias (Dyskinesia) 05/2009 - 11/2005
2	Carcinoma (Carcinomatosis) 11/2005 - 03/2005
1	Hearing Loss (Hearing Impairment) 01/2022
1	Acoustic Neuroma (Acoustic Neurinoma) 01/2021
1	Neurilemmoma (Schwannoma) 01/2021
1	Microcephaly 01/2017
1	Inflammation (Inflammations) 01/2016
1	Rickets (Rachitis) 03/2015
1	Neuroinflammatory Diseases 01/2014
1	Breast Neoplasms (Breast Cancer) 09/2013
1	Brain Diseases (Brain Disorder) 01/2013
1	Edema (Dropsy) 07/2011
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2011
1	Lymphoma (Lymphomas) 04/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2011
1	Oligodendroglioma 01/2011
1	Central Nervous System Diseases (CNS Diseases) 11/2010
1	Arthritis (Polyarthritis) 04/2010
1	Rheumatoid Arthritis 04/2010
1	Joint Diseases (Joint Disease) 04/2010
1	Testicular Neoplasms (Testicular Cancer) 10/2009
1	Communicable Diseases (Infectious Diseases) 06/2009

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2013 - 11/2005
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2007
3	Oxygen (Dioxygen)IBA 04/2012 - 12/2007
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2008
2	Small Interfering RNA (siRNA)IBA 12/2015 - 04/2012
2	Vitamin D FDA LinkGeneric 03/2015 - 01/2014
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2014 - 01/2013
2	Hormones (Hormone)IBA 01/2014 - 04/2002
2	cadherin 5IBA 06/2013 - 01/2013
2	Thrombospondin 1IBA 05/2011 - 04/2004
2	VimentinIBA 05/2011 - 02/2010
2	EnzymesIBA 05/2011 - 03/2005
2	pyrazolanthroneIBA 03/2010 - 01/2008
2	Levodopa (L Dopa)FDA LinkGeneric 05/2009 - 11/2005
2	Messenger RNA (mRNA)IBA 11/2006 - 11/2005
2	Complementary DNA (cDNA)IBA 11/2005 - 03/2005
1	Aquaporins (Water Channels)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	EphA4 ReceptorIBA 04/2017
1	LigandsIBA 04/2017
1	Ephrin-B3 (Ephrin B3)IBA 04/2017
1	salicylhydroxamic acid (SHAM)IBA 11/2016
1	Biological ProductsIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	CytokinesIBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Casein Kinase II (Casein Kinase 2)IBA 12/2015
1	Contrast MediaIBA 03/2015
1	Bevacizumab (Avastin)FDA Link 09/2013
1	FilaminsIBA 06/2013
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2013
1	Metalloproteases (Metalloproteinases)IBA 01/2013
1	Fibrinolysin FDA Link 07/2011
1	shark cartilage extractIBA 07/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2011
1	OligonucleotidesIBA 05/2011
1	ImmunosorbentsIBA 05/2011
1	Histones (Histone)IBA 04/2011
1	Signal Recognition ParticleIBA 04/2011
1	Aspartic Acid (Aspartate)FDA Link 01/2011
1	Sirtuin 1IBA 01/2011
1	malic acid (malate)IBA 01/2011
1	NAD (NADH)IBA 01/2011
1	MicroRNAs (MicroRNA)IBA 01/2011
1	S100A12 ProteinIBA 04/2010
1	Janus KinasesIBA 03/2010
1	Tissue ExtractsIBA 02/2010
1	Indicators and Reagents (Reagents)IBA 10/2009
1	Pharmaceutical PreparationsIBA 06/2009
1	ElementsIBA 06/2009
1	Oxidopamine (6 Hydroxydopamine)IBA 05/2009
1	Nylons (Nylon)IBA 04/2008
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2008
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2008
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2008
1	Mitogen-Activated Protein KinasesIBA 01/2008
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2008

Therapy/Procedure

10	Therapeutics 01/2022 - 11/2005
3	Lasers (Laser) 01/2021 - 04/2011
2	Radiotherapy 09/2010 - 06/2006
1	Euthanasia (Mercy Killing) 04/2017
1	Deep Brain Stimulation 01/2016
1	Synchrotrons 12/2015
1	Cytoreduction Surgical Procedures 01/2014
1	Drug Therapy (Chemotherapy) 09/2010